Skip to main content
. 2023 Oct 24;2023(10):CD014722. doi: 10.1002/14651858.CD014722.pub2

Nisar 2021.

Methods Abstract; full‐text is not available.
Study design: RCT
Country: Pakistan
Participants Patients of end‐stage renal disease
Inclusion criteria: 
a. patients of end‐stage renal disease
Exclusion criteria:
not specified
Stated purpose: to find out the effect of supportive‐expressive group therapy in end‐stage kidney disease patients on the outcome of better health‐related quality of life and survival
Interventions Intervention:
supportive‐expressive group therapy
Control:
control group (not specified)
Outcomes Participants'outcomes of interest for this review
  1. Diagnosis of mental disorders (newly diagnosed depressive disorders)

  2. Mental health symptoms/depression (mood elevation)

  3. Social outcomes (social life)

  4. Quality of life


Economic outcomes
Nil
Time points: baseline, post‐intervention (not specified)
Notes Source of funding: not specified
Prospective trial registration number: not specified